Secukinumab Shows Benefit for Hidradenitis Suppurativa at 1 Year ...Middle East

Medscape - News
Currently, the tumor necrosis factor inhibitor adalimumab is the only biologic therapy approved for the treatment of moderate to severe hidradenitis suppurativa. MDedge News

Hence then, the article about secukinumab shows benefit for hidradenitis suppurativa at 1 year was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Secukinumab Shows Benefit for Hidradenitis Suppurativa at 1 Year )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News